Page 30 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

Lief Labs CEO Adel Villalobos a Member of the Los Angeles CEO Council Delivers Keynote Address at the 5th Annual LA County Bioscience Forum

VALENCIA, CA / ACCESSWIRE / October 18, 2022 / Lief Labs, a premier formulation and product development innovator and manufacturer of dietary supplements, is pleased to announce that Lief's CEO & Founder ....

Los Angeles , Kostenloser Wertpapierhandel , Cathy Loos , Adel Villalobos , Product Development , Kloos Co , Bioscience Forum On , Council Member , Bioscience Forum , Lief Labs , Collaboration Hub , Culver City , Current Good Manufacturing Practice , Media Inquiries ,

Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Mérieux Equity Partners

The financing will enable the company to advance its lead candidate to the clinic and to build a pipeline of next-generation antibody-drug conjugates (ADCs)Its proprietary ADC technology opens the door ....

France General , City Of , United Kingdom , Jean Guillaume Lafay , Fondation Fournier Majoie , Mablink Adcs , Graziano Seghezzi , Alpha Fra , Mablink Bioscience , Kostenloser Wertpapierhandel , Florian Denis , Europe Venture Fund , Sofinnova Partners , Equity Partners , Chief Executive Officer , Managing Partner , Pertinence Invest , Investment Director , Elaia Partners , Sham Innovation Sant , Turenne Capital , Simba Sant , Folate Receptor Alpha , Venture Capital , Venture Fund , M 233 Rieux ,

ObsEva SA: ObsEva Announces IND Approval for Yuyuan Bioscience's Phase 1 Clinical Trial of Nolasiban in China

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - October 13, 2022 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel ....

United States , Yuyuan Bioscience , Shauna Dillon , Brian Ocallaghan , Exchange Commission , Chinese National Medical Products Administration , Swiss Exchange , Drug Evaluation , Chinese National Medical Products , Peoples Republic , Briano Callaghan , Nasdaq Global Select Market , Private Securities Litigation Reform Act , Risk Factors , Annual Report ,

Satellos Bioscience Inc.: Satellos Bioscience Announces OTCQB Listing in the United States

Toronto, Ontario (Newsfile Corp. - October 6, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Corporation"), a drug discovery company aimed at developing therapeutics ....

United States , Christina Cameron , Ryan Mitchell , Michael Rudnicki , Frank Gleeson , Amphotericinb Technologies Inc , Exchange Commission , Regulatory Services Provider , Newsfile Corp , Satellos Co , Satellos Bioscience Inc , Venture Exchange , Business Development , Satellos Co Founder , Real Time Level ,

Skye Bioscience, Inc.: Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.

Additional capital from Arrangement Agreement expected to fund Skye's Phase 1 and 2 clinical studies of proprietary synthetic cannabinoid-derivative therapeutic targeting glaucoma
San Diego, California (Newsfile ....

San Diego , United States , United Kingdom , Skye Bioscience , Punit Dhillon , Emerald Health Sciences Inc , Skye Bioscience Inc , Exchange Commission , Supreme Court , British Columbia Supreme Court On , California Newsfile Corp , Arrangement Of Emerald Health Therapeutics Inc , Canadian Securities Exchange , Emerald Health Therapeutics , Arrangement Agreement , Emerald Health Sciences , Regulations K , Stock Purchase Plan , Incentive Plan , British Columbia , Canadian Securities , Investigational New Drug , British Columbia Supreme Court , Relations Email , Risk Factors ,